Chlorpheniramine Maleate

CHEMBL1659 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
390.9 g/mol
LogP
Phase
4

The maleate salt form of chlorpheniramine is the most commonly used preparation of this first-generation antihistamine, found in numerous oral cold and allergy medications. It relieves sneezing, runny nose, and itching but causes sedation in many patients. Caution is needed in elderly patients due to anticholinergic side effects including urinary retention and confusion.

Masse moléculaire

390,9000 g/mol

TPSA

90,70 Ų

Aires thérapeutiques

Mécanisme d'action

Competitively blocks histamine H1 receptors on effector cells, preventing histamine-mediated vasodilation, increased vascular permeability, bronchoconstriction, and pruritus. First-generation agents also cross the blood-brain barrier, causing sedation.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Competitively blocks histamine H1 receptors on effector cells, preventing histamine-mediated vasodilation, increased vascular permeability, bronchoconstriction, and pruritus. First-generation agents also cross the blood-brain barrier, causing sedation.

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O

InChI

InChI=1S/C16H19ClN2.C4H4O4/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13;5-3(6)1-2-4(7)8/h3-9,11,15H,10,12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-

Molecular Formula

C20H23ClN2O4

HBD / HBA

2 / 6

Liaisons Rotatives

7

Atomes Lourds

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

The maleate salt form of chlorpheniramine is the most commonly used preparation of this first-generation antihistamine, found in numerous oral cold and allergy medications. It relieves sneezing, runny nose, and itching but causes sedation in many patients. Caution is needed in elderly patients due to anticholinergic side effects including urinary retention and confusion.

Competitively blocks histamine H1 receptors on effector cells, preventing histamine-mediated vasodilation, increased vascular permeability, bronchoconstriction, and pruritus. First-generation agents also cross the blood-brain barrier, causing sedation.

Yes, Chlorpheniramine Maleate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1659. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5281068. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.